BCL-2 Family Inhibition Enhances mTORC1/2 Inhibition in <i>PIK3CA</i> -Mutant Colorectal Cancer

Rebecca A. DeStefanis, Alexa E. Schmitz, Alyssa K. Steimle, Susan N. Payne, Gioia C. Sha, Autumn M. Olson, Alec Cornelio, Anna E.L. Lippert, Sean G. Kraus, Katherine A. Johnson, Peter F. Favreau, Amani Gillette, Christopher Babiarz, Devon Miller, Carley M. Sprackling, Cheri A. Pasch, Stephanie Pritzl, Dana R. Van De Hey, Demetra P. Korkos, Tyler M. Foley, Alexander E. Yueh, Aurora L.J.X. Greane, Linda Clipson, Melissa C. Skala, Dustin A. Deming

Open source

DOI
10.1158/1535-7163.mct-24-1096
Published
2025-07-09
Container
Molecular Cancer Therapeutics
Publisher
American Association for Cancer Research (AACR)
Open access
unknown

Credibility signals

uncertain Score 64/100 under policy 1.0.0. This is a metadata assessment, not a judgment of the paper's conclusions.

Show all credibility signals

Cite this work

BibTeX

@article{allodium:10.1158/1535-7163.mct-24-1096,
  title = {BCL-2 Family Inhibition Enhances mTORC1/2 Inhibition in
                    <i>PIK3CA</i>
                    -Mutant Colorectal Cancer},
  author = {Rebecca A. DeStefanis and Alexa E. Schmitz and Alyssa K. Steimle and Susan N. Payne and Gioia C. Sha and Autumn M. Olson and Alec Cornelio and Anna E.L. Lippert and Sean G. Kraus and Katherine A. Johnson and Peter F. Favreau and Amani Gillette and Christopher Babiarz and Devon Miller and Carley M. Sprackling and Cheri A. Pasch and Stephanie Pritzl and Dana R. Van De Hey and Demetra P. Korkos and Tyler M. Foley and Alexander E. Yueh and Aurora L.J.X. Greane and Linda Clipson and Melissa C. Skala and Dustin A. Deming},
  year = {2025},
  journal = {Molecular Cancer Therapeutics},
  doi = {10.1158/1535-7163.mct-24-1096},
  url = {https://doi.org/10.1158/1535-7163.mct-24-1096}
}

RIS

TY  - JOUR
TI  - BCL-2 Family Inhibition Enhances mTORC1/2 Inhibition in
                    <i>PIK3CA</i>
                    -Mutant Colorectal Cancer
AU  - Rebecca A. DeStefanis
AU  - Alexa E. Schmitz
AU  - Alyssa K. Steimle
AU  - Susan N. Payne
AU  - Gioia C. Sha
AU  - Autumn M. Olson
AU  - Alec Cornelio
AU  - Anna E.L. Lippert
AU  - Sean G. Kraus
AU  - Katherine A. Johnson
AU  - Peter F. Favreau
AU  - Amani Gillette
AU  - Christopher Babiarz
AU  - Devon Miller
AU  - Carley M. Sprackling
AU  - Cheri A. Pasch
AU  - Stephanie Pritzl
AU  - Dana R. Van De Hey
AU  - Demetra P. Korkos
AU  - Tyler M. Foley
AU  - Alexander E. Yueh
AU  - Aurora L.J.X. Greane
AU  - Linda Clipson
AU  - Melissa C. Skala
AU  - Dustin A. Deming
PY  - 2025
JO  - Molecular Cancer Therapeutics
DO  - 10.1158/1535-7163.mct-24-1096
UR  - https://doi.org/10.1158/1535-7163.mct-24-1096
ER  - 

APA

DeStefanis, R. A., Schmitz, A. E., Steimle, A. K., Payne, S. N., Sha, G. C., Olson, A. M., Cornelio, A., Lippert, A. E., Kraus, S. G., Johnson, K. A., Favreau, P. F., Gillette, A., Babiarz, C., Miller, D., Sprackling, C. M., Pasch, C. A., Pritzl, S., Hey, D. R. V. D., Korkos, D. P., Foley, T. M., Yueh, A. E., Greane, A. L., Clipson, L., Skala, M. C., & Deming, D. A. (2025). BCL-2 Family Inhibition Enhances mTORC1/2 Inhibition in <i>PIK3CA</i> -Mutant Colorectal Cancer. Molecular Cancer Therapeutics. https://doi.org/10.1158/1535-7163.mct-24-1096

Source records